|
|
Article: Analysis of Teva Pharmaceutical Industries Ltd.
- Article from:
- M2 Presswire
- Article date:
- June 22, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-22 June 2007-Biotech News: Analysis of Teva Pharmaceutical Industries Ltd(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:22062007
Analysis of Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA)
Teva Pharmaceutical Industries Limited engages in the development, manufacture, and marketing of generic and human pharmaceuticals, active pharmaceutical ingredients (APIs), and animal health pharmaceutical products. It offers generic pharmaceutical products in various dosage forms, including tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company also provides specialty pharmaceutical products, such as respiratory, ...